1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs : Results from four Nordic countries
(
- Contribution to journal › Article
- 2021
-
Mark
Biomechanical properties of common carotid arteries assessed by circumferential 2D strain and β stiffness index in patients with ankylosing spondylitis
(
- Contribution to journal › Article
- 2016
-
Mark
Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis
2016) In Annals of the Rheumatic Diseases(
- Contribution to journal › Article
- 2012
-
Mark
Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis
(
- Contribution to journal › Article
- 2008
-
Mark
Anti-TNF therapy in RA and risk of Acute Myocardial Infarction (AMI), Stroke and any Cardiovascular (CVD) events up to 7 years after treatment stare
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.900-900(
- Contribution to journal › Published meeting abstract
-
Mark
Why do women with early RA respond less well to MTX than men? Gender as a determinant of response in the initial phase of the Swefot trial
(
- Contribution to journal › Published meeting abstract